The TGA is “making inquiries” after GP telehealth corporate Eucalyptus Health emailed patients to say its doctors could now prescribe Ozempic (semaglutide) for weight loss.

The four-year-old company — which has raised at least $60 million from investors — runs multiple telehealth websites, including men’s health site Pilot and women’s health site Juniper.

Eucalyptus Health clinical director Dr Matt Vickers, a GP, has confirmed that Juniper patients received emails several weeks ago advising that semaglutide was now available on its Weight Reset Program as an alternative to liraglutide (Saxenda).

A TGA spokesperson said the watchdog was “aware of the email that was sent and is making inquiries” given the ban on advertising prescription medications to the public.